A new study in the Annals of Internal Medicine finds that most of the commonly employed tools to calculate cardiovascular risk seriously overestimate the risk of people today.
Calculating cardiovascular risk has become a central and highly controversial component of cardiovascular guidelines. Now a study in the Annals of Internal Medicine finds that most of the commonly employed tools seriously overestimate the risk of people today.
Researchers used data from 4227 people enrolled in the Multi-Ethnic Study of Atherosclerosis between 2000 and 2002 to assess the predictive accuracy of the new AHA/ACC atherosclerotic cardiovascular disease tool and 4 alternative risk scores: FRS-CHD, the ATP-III-FRS-CHD, the Reynolds Risk Score (RRS), and the FRS-CVD.
They found that 4 out of the 5 scores overestimated risk for men by as little as 37% and by as much as 154% and for women by as little as 8% and as much as 67%. The RRS overestimated risk in men by 9% but underestimated risk in women by 21%.
Read more at Forbes: http://onforb.es/1Am9bfT
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Insurance Coverage Limits JAKi Therapy Access for Patients With AA, Especially Non-White Populations
April 25th 2024A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
Read More